Background: An update on the degree to which patients with type 2 diabetes in Canada
achieve treatment targets is needed to document progress and identify subgroups that need …

Background Respiratory tract infection (RTI) is the leading reason for avoidable
antimicrobial use in primary care, yet provider-level feedback on its use is only available in …

Objectives Recent diabetes guidelines call for prescribing sodium-glucose cotransporter-2
inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) for end-organ …

Aims Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are largely
managed in primary care, but their intersection in terms of disease burden, healthcare …

Primary care antimicrobial stewardship programs are virtually non-existent. Using electronic
medical record (EMR) data for an interrupted time series study, the authors examined the …

Objectives Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose
cotransporter-2 inhibitors (SGLT2i) have shown cardiorenal benefits independent of their …

This publication may be reproduced in whole or in part for non-commercial purposes only
and on the condition that the original content of the publication or portion of the publication …

Résumé Contexte: Une vérification du degré d'atteinte des cibles thérapeutiques pour le
diabète de type 2 au Canada s' impose afin d'en documenter l'évolution et d'identifier les …

This publication may be reproduced in whole or in-part for non-commercial purposes only
and on the condition that the original content of the publication or portion of the publication …

Breathlessness Page 1 EDUCATION MEDICATION IN REVIEW 96 OCTOBER 2021 AJP
Breathlessness Breathlessness is a cardinal symptom for cardiorespiratory diseases, leading …